Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert Zeiser

Showing results (11-20 of 372) with videos related to

Pageof 38
Sort By:
Seminars in Arthritis and Rheumatism|March 3, 2025
Immunotherapy in cancerRobert Zeiser
Oncology Research and Treatment|May 14, 2015
Activation of Innate Immunity in Graft-versus-Host Disease: Implications for Novel Targets?Robert Zeiser
Blood|June 27, 2024
Introduction to a review series on oncogenic signaling and immune evasion in hematologic malignanciesRobert Zeiser
Frontiers in Immunology|August 1, 2020
NLRP3 Inflammasome Activation in Cancer: A Double-Edged SwordShaima'a Hamarsheh, Robert Zeiser
Current Opinion in Pharmacology|April 23, 2025
Strategies to enhance anti-leukaemia immunotherapyMemnon Lysandrou, Robert Zeiser
Transplantation and Cellular Therapy|July 2, 2021
Deciphering the role of Minor histocompatibility antigens for acute graft-versus-host diseaseSophie Giesler, Robert Zeiser
Frontiers in Immunology|June 29, 2023
Editorial: Current concepts of cellular and biological drugs to modulate regulatory T cell activity in the clinic, volume IIValentin Wenger, Robert Zeiser
Frontiers in Immunology|November 8, 2016
The Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host DiseasePetya Apostolova, Robert Zeiser
Brain Communications|June 30, 2023
Immune checkpoint inhibitor induced neurocognitive deficits in patientsRobert Zeiser, Marco Prinz
The Lancet. Oncology|December 3, 2014
Harnessing GVHD by interleukin-6 receptor blockadeJürgen Finke, Robert Zeiser
Pageof 38

Showing results (11-20 of 372) with videos related to

Sort By:
Pageof 38
Seminars in Arthritis and Rheumatism|March 3, 2025
Immunotherapy in cancerRobert Zeiser
Oncology Research and Treatment|May 14, 2015
Activation of Innate Immunity in Graft-versus-Host Disease: Implications for Novel Targets?Robert Zeiser
Blood|June 27, 2024
Introduction to a review series on oncogenic signaling and immune evasion in hematologic malignanciesRobert Zeiser
Frontiers in Immunology|August 1, 2020
NLRP3 Inflammasome Activation in Cancer: A Double-Edged SwordShaima'a Hamarsheh, Robert Zeiser
Current Opinion in Pharmacology|April 23, 2025
Strategies to enhance anti-leukaemia immunotherapyMemnon Lysandrou, Robert Zeiser
Transplantation and Cellular Therapy|July 2, 2021
Deciphering the role of Minor histocompatibility antigens for acute graft-versus-host diseaseSophie Giesler, Robert Zeiser
Frontiers in Immunology|June 29, 2023
Editorial: Current concepts of cellular and biological drugs to modulate regulatory T cell activity in the clinic, volume IIValentin Wenger, Robert Zeiser
Frontiers in Immunology|November 8, 2016
The Role of Purine Metabolites as DAMPs in Acute Graft-versus-Host DiseasePetya Apostolova, Robert Zeiser
Brain Communications|June 30, 2023
Immune checkpoint inhibitor induced neurocognitive deficits in patientsRobert Zeiser, Marco Prinz
The Lancet. Oncology|December 3, 2014
Harnessing GVHD by interleukin-6 receptor blockadeJürgen Finke, Robert Zeiser
Pageof 38